14379 results found.
Opportunity in Value-Based Care Lies in Impacting Quality
By Patrick Vega, M.S., Vizient The purpose of this quarterly column is to introduce and discuss key considerations for device companies from the perspective of their customers: hospitals, health systems and physicians. ...
Episurf Medical Reaches Milestones in Patient Population
Episurf Medical announced that more than 100 Episealer® patients have had their knee implants for more than three years, and more than 200 patients have ...
Aesculap activL Lumbar Disc: 5-Year Study Results
At five-year follow-up, Aesculap Implant Systems' activL® lumbar disc was found to more effectively preserve range of motion vs. first-generation lumbar total dis...
Zimmer Biomet Gains FDA Approval for Tether Scoliosis Treatment
Zimmer Biomet received FDA approval for The Tether™, a vertebral body tethering system that offers an alternative to fusion in the treatment o...
SeaSpine Launches Mariner MIS Posterior Fixation System
SeaSpine commenced limited launch of the Mariner® MIS Posterior Fixation System.
aap Implantate Down in 2Q19 on International Softness
aap Implantate reports 2Q19 revenue of €2.5MM (USD $2.8MM), -7% vs. 2Q18.
WishBone Medical Gains Distribution Rights to OsteoCrete Bone Void Filler
WishBone Medical entered into a private label distribution agreement with Bone Solutions for worldwide rights to sell OsteoCrete®...
NuVasive Specialized Orthopedics Hits 10,000 Implant Milestone with Precice Limb Lengthening
NuVasive Specialized Orthopedics achieved 10,000 implantations of the Precice® intramedullary nail, used to treat conditions related to limb leng...
OIC Launches Trochanteric Antegrade Femur Intramedullary Nail
The Orthopaedic Implant Company introduced the Trochanteric Antegrade Femur Intramedullary Nail, part of the OIC Intramedullary Nail System.
Vericel Posts Record Growth in 2Q19 on New Surgeons
Vericel reports 2Q19 MACI revenue of USD $20.8MM, +47.5% vs. 2Q18.
Bioventus: DUROLANE Update in Australia, New Zealand
Bioventus is launching its single-injection DUROLANE SJ hyaluronic acid-based OA treatment and received expanded indications for DUROLANE in Australia and New Ze...
Anika Announces First Human Procedure with Injectable Bone Repair Therapy
Anika Therapeutics announced completion of the first human surgical procedure with the company's injectable HA-based therapy to treat bone voids a...
Loci Orthopaedics Gains Funding for Thumb Base Joint Implant
Loci Orthopaedics was awarded a grant of €2.5MM (~USD $2.8MM) to support commercialization of the InDx implant to treat arthritis of the thumb ba...
SI-BONE Continues Growth in 2Q19 on Payor Coverage
SI-BONE reports 2Q19 revenue of USD $16.3MM, +19.4% vs. 2Q18.
OrthoPediatrics Continues Record Growth in 2Q19
OrthoPediatrics reports 2Q19 revenue of USD $18.2MM, +20.7% vs. 2Q18.
Xtant Losses Continue in 2Q19 on Lumbar Implant Recall
Xtant reports 2Q19 revenue of USD $15.3MM, -18.5% vs. 2Q18.
Stryker to Acquire Sterilization Specialist TSO3
Stryker agrees to acquire sterilization specialist TSO3 for CAD $68.4MM (USD $51.7MM)
Spineology Launches Duo Angled Instrumentation
Spineology introduced Duo™ Angled Instrumentation to support access to the L4-L5 disc space when the iliac crest prevents collinear access.
Kinamed CarboJet Bone Preparation System Study Results
Studies demonstrate that use of Kinamed's CarboJet® CO2 Bone Preparation System yields increased bone cement penetration in total knee arthroplasty, even ...
SeaSpine Up +8% in 2Q19 on New Product Launches
SeaSpine reports 2Q19 revenue of USD $39.3MM, +8% vs. 2Q18.
Wright Medical Grew 11.8% in 2Q19 Amid Cartiva Woes
Wright Medical reports 2Q19 revenue of USD $229.7MM, +11.8% vs. 2Q18.
Collagen Matrix Acquired by Private Equity Firm
Collagen Matrix, manufacturer of collagen- and mineral-based products for tissue and bone repair and regeneration, was acquired by Linden Capital Partners
Orthofix Up +3.9% in 2Q19 on Biologics Outperformance
Orthofix reports 2Q19 revenue of USD $115.9MM, +3.9% vs. 2Q18.
Seikagaku up 5.9% in 2Q19 on US Reimbursement
Seikagaku reports FY 1Q19 revenue of ¥7,649MM (USD $69.1MM), +5.9% vs. FY 1Q18.
NanoFUSE Launches Biologic Product in Panama
NanoFUSE Biologics is introducing its bioactive glass + DBM biologic in Panama.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group